First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 7.12 AUD -0.28% Market Closed
Updated: May 9, 2024

Mayne Pharma Group Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Selling, General & Administrative Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Selling, General & Administrative
-AU$190m
CAGR 3-Years
-13%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Selling, General & Administrative
-AU$14.9m
CAGR 3-Years
-7%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Selling, General & Administrative
-AU$5.9m
CAGR 3-Years
-50%
CAGR 5-Years
-23%
CAGR 10-Years
-10%
Botanix Pharmaceuticals Ltd
ASX:BOT
Selling, General & Administrative
-AU$10m
CAGR 3-Years
-22%
CAGR 5-Years
-37%
CAGR 10-Years
-34%
Probiotec Ltd
ASX:PBP
Selling, General & Administrative
-AU$33.7m
CAGR 3-Years
-19%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Selling, General & Administrative
-AU$4.7m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Selling, General & Administrative?
Selling, General & Administrative
-190m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Selling, General & Administrative amounts to -190m AUD.

What is Mayne Pharma Group Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-7%

Over the last year, the Selling, General & Administrative growth was -42%. The average annual Selling, General & Administrative growth rates for Mayne Pharma Group Ltd have been -13% over the past three years , -7% over the past five years .